Kaempferia parviflora Extracellular Vesicle Loaded with Clarithromycin for the Treatment of Helicobacter pylori Infection

References

• Wattanathorn J, Tong-Un T, Thukham-Mee W, Weerapreeyakul N. A functional drink containing Kaempferia parviflora extract increases cardiorespiratory fitness and physical flexibility in adult volunteers. Foods. 2023;12(18):3411. doi:10.3390/foods12183411
   PubMed Web of Science ®Google Scholar
• Hairunisa I, Bakar MFA, Da’i M, Bakar FIA, Syamsul ES. Cytotoxic activity, anti-migration and in silico study of black ginger (Kaempferia parviflora) extract against breast cancer cell. Cancer. 2023;15:10. doi:10.3390/cancers15102785
   Google Scholar
• Sitthichai P, Chanpirom S, Maneerat T, et al. Kaempferia parviflora rhizome extract as potential anti-acne ingredient. Molecules. 2022;27(14). doi:10.3390/molecules27144401
   PubMed Web of Science ®Google Scholar
• Takuathung MN, Potikanond S, Sookkhee S, et al. Anti-psoriatic and anti-inflammatory effects of Kaempferia parviflora in keratinocytes and macrophage cells. Biomed Pharmacother. 2021;143:112229. doi:10.1016/j.biopha.2021.112229
   PubMed Web of Science ®Google Scholar
• Paramee S, Sookkhee S, Sakonwasun C, et al. Anti-cancer effects of Kaempferia parviflora on ovarian cancer SKOV3 cells. BMC Complement Altern Med. 2018;18(1):178. doi:10.1186/s12906-018-2241-6
   PubMedGoogle Scholar
• Chen D, Li H, Li W, Feng S, Deng D. Kaempferia parviflora and its methoxyflavones: chemistry and biological activities. Evid Based Complement Alternat Med. 2018;2018:4057456. doi:10.1155/2018/4057456
   PubMed Web of Science ®Google Scholar
• Chaichanawongsaroj N, Amonyingcharoen S, Saifah E, Poovorawan Y. The effects of Kaempferia parviflora on anti-internalization activity of Helicobacter pylori to HEp-2 cells. Afr J Biotechnol. 2010;9:30.
   Google Scholar
• Chaichanawongsaroj N, Amonyingcharoen S, Pattiyathanee P, R-k V, Poovorawan Y. Anti-Helicobacter pylori and anti-internalization activities of Thai folk remedies used to treat gastric ailments. J Med Plants Res. 2012;6(8):1389–1393. doi:10.5897/jmpr10.552
   Google Scholar
• Nemidkanam V, Kato Y, Kubota T, Chaichanawongsaroj N. Ethyl acetate extract of Kaempferia parviflora inhibits Helicobacter pylori-associated mammalian cell inflammation by regulating proinflammatory cytokine expression and leukocyte chemotaxis. BMC Complement Med Ther. 2020;20(1):124. doi:10.1186/s12906-020-02927-2
   PubMedGoogle Scholar
• de la Canal L, Pinedo M. Extracellular vesicles: a missing component in plant cell wall remodeling. J Exp Bot. 2018;69(20):4655–4658. doi:10.1093/jxb/ery255
   PubMed Web of Science ®Google Scholar
• Wang B, Zhuang X, Deng ZB, et al. Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit. Mol Ther. 2014;22(3):522–534. doi:10.1038/mt.2013.190
   PubMed Web of Science ®Google Scholar
• Zhang M, Xiao B, Wang H, et al. Edible ginger-derived nano-lipids loaded with doxorubicin as a novel drug-delivery approach for colon cancer therapy. Mol Ther. 2016;24(10):1783–1796. doi:10.1038/mt.2016.159
   PubMed Web of Science ®Google Scholar
• Zhuang X, Deng ZB, Mu J, et al. Ginger-derived nanoparticles protect against alcohol-induced liver damage. J Extracell Vesicles. 2015;4(1):28713. doi:10.3402/jev.v4.28713
   PubMed Web of Science ®Google Scholar
• Deng Z, Rong Y, Teng Y, et al. Broccoli-derived nanoparticle inhibits mouse colitis by activating dendritic cell AMP-activated protein kinase. Mol Ther. 2017;25(7):1641–1654. doi:10.1016/j.ymthe.2017.01.025
   PubMed Web of Science ®Google Scholar
• Woith E, Guerriero G, Hausman JF, et al. Plant extracellular vesicles and nanovesicles: focus on secondary metabolites, proteins and lipids with perspectives on their potential and sources. Int J Mol Sci. 2021;22(7). doi:10.3390/ijms22073719
   PubMed Web of Science ®Google Scholar
• Yang C, Zhang M, Merlin D. Advances in plant-derived edible nanoparticle-based lipid nano-drug delivery systems as therapeutic nanomedicines. J Mater Chem B. 2018;6(9):1312–1321. doi:10.1039/C7TB03207B
   PubMed Web of Science ®Google Scholar
• Thery C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750. doi:10.1080/20013078.2018.1535750
   PubMed Web of Science ®Google Scholar
• Nemidkanam V, Chaichanawongsaroj N. Characterizing Kaempferia parviflora extracellular vesicles, a nanomedicine candidate. PLoS One. 2022;17(1):e0262884. doi:10.1371/journal.pone.0262884
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Camargo MC, El-Omar E, et al. Helicobacter pylori infection. Nat Rev Dis Primers. 2023;9(1):19. doi:10.1038/s41572-023-00431-8
   PubMed Web of Science ®Google Scholar
• Kumar S, Patel GK, Ghoshal UC. Helicobacter pylori-Induced inflammation: possible factors modulating the risk of gastric cancer. Pathogens. 2021;10(9). doi:10.3390/pathogens10091099
   Web of Science ®Google Scholar
• Salvatori S, Marafini I, Laudisi F, Monteleone G, Stolfi C. Helicobacter pylori and Gastric Cancer: pathogenetic Mechanisms. Int J Mol Sci. 2023;24(3). doi:10.3390/ijms24032895
   Web of Science ®Google Scholar
• Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017;112(2):212–239. doi:10.1038/ajg.2016.563
   PubMed Web of Science ®Google Scholar
• Grübel P, Cave DR. Factors affecting solubility and penetration of clarithromycin through gastric mucus. Aliment. Pharmacol. Ther. 1998;12(6):569–576.
   PubMed Web of Science ®Google Scholar
• Khosravian P, Khoobi M, Ardestani MS, et al. Enhancement antimicrobial activity of clarithromycin by amine functionalized mesoporous silica nanoparticles as drug delivery system. Lett Drug Des Discovery. 2018;15(7):787–795. doi:10.2174/1570180815666180117155818
   Web of Science ®Google Scholar
• Makoni PA, Khamanga SM, Walker RB. Muco-adhesive clarithromycin-loaded nanostructured lipid carriers for ocular delivery: formulation, characterization, cytotoxicity and stability. J Drug Delivery Sci Technol. 2021;61. doi:10.1016/j.jddst.2020.102171
   Web of Science ®Google Scholar
• Sung J, Yang C, Viennois E, Zhang M, Merlin D. Isolation, purification, and Characterization of Ginger-derived Nanoparticles (GDNPs) from ginger, rhizome of Zingiber officinale. Bio-Protocol. 2019;9(19):e3390. doi:10.21769/BioProtoc.3390
   PubMed Web of Science ®Google Scholar
• Yang X, Shi G, Guo J, Wang C, He Y. Exosome-encapsulated antibiotic against intracellular infections of methicillin-resistant Staphylococcus aureus. Int J Nanomed. 2018;13:8095–8104. doi:10.2147/IJN.S179380
   PubMed Web of Science ®Google Scholar
• Askarizadeh M, Esfandiari N, Honarvar B, Sajadian SA, Azdarpour A. Kinetic modeling to explain the release of medicine from drug delivery systems. ChemBioEng Rev. 2023;10(6):1006–1049. doi:10.1002/cben.202300027
   Web of Science ®Google Scholar
• Tharmalingam N, Kim S-H, Park M, et al. Inhibitory effect of piperine on Helicobacter pylori growth and adhesion to gastric adenocarcinoma cells. Infect Agent Cancer. 2014;9:43.
   PubMed Web of Science ®Google Scholar
• Aumpan N, Mahachai V, Vilaichone RK. Management of Helicobacter pylori infection. JGH Open. 2023;7(1):3–15. doi:10.1002/jgh3.12843
   PubMed Web of Science ®Google Scholar
• Jain SK, Haider T, Kumar A, Jain A. Lectin-conjugated clarithromycin and acetohydroxamic acid-loaded PLGA nanoparticles: a novel approach for effective treatment of H. pylori. AAPS Pharm Sci Tech. 2016;17(5):1131–1140. doi:10.1208/s12249-015-0443-5
   PubMed Web of Science ®Google Scholar
• Geng S, Liu X, Xu H, et al. Clarithromycin ion pair in a liposomal membrane to improve its stability and reduce its irritation caused by intravenous administration. Expert Opin Drug Deliv. 2016;13(3):337–348. doi:10.1517/17425247.2016.1123247
   PubMed Web of Science ®Google Scholar
• Zeng H, Guo S, Ren X, Wu Z, Liu S, Yao X. Current strategies for exosome cargo loading and targeting delivery. Cells. 2023;12(10). doi:10.3390/cells12101416
   Web of Science ®Google Scholar
• Fu S, Wang Y, Xia X, Zheng JC. Exosome engineering: current progress in cargo loading and targeted delivery. NanoImpact. 2020;20. doi:10.1016/j.impact.2020.100261
   Web of Science ®Google Scholar
• Gong C, Tian J, Wang Z, et al. Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy. J Nanobiotechnology. 2019;17(1):93. doi:10.1186/s12951-019-0526-7
   PubMed Web of Science ®Google Scholar
• Xiao Q, Zhao W, Wu C, et al. Lemon-Derived extracellular vesicles nanodrugs enable to efficiently overcome cancer multidrug resistance by endocytosis-triggered energy dissipation and energy production reduction. Adv Sci. 2022;9(20):e2105274. doi:10.1002/advs.202105274
   Web of Science ®Google Scholar
• Sukreet S, Silva BVRE, Adamec J, Cui J, Zempleni J. Sonication and short-term incubation alter the content of bovine milk exosome cargos and exosome bioavailability (OR26-08-19). Curr. Dev. Nutr. 2019;3. doi:10.1093/cdn/nzz033.OR26-08-19
   PubMedGoogle Scholar
• Nizamudeen ZA, Xerri R, Parmenter C, et al. Low-power sonication can alter extracellular vesicle size and properties. Cells. 2021;10(9). doi:10.3390/cells10092413
   PubMed Web of Science ®Google Scholar
• Danaei M, Dehghankhold M, Ataei S, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2). doi:10.3390/pharmaceutics10020057
   PubMed Web of Science ®Google Scholar
• Moon K, Hur J, Kim KP, Lee K, Kang JY. Surface‐functionalizable plant‐derived extracellular vesicles for targeted drug delivery carrier using grapefruit. Adv. Mater. Interfaces. 2023;10(22). doi:10.1002/admi.202300220
   Web of Science ®Google Scholar
• Hallal S, Tuzesi A, Grau GE, Buckland ME, Alexander KL. Understanding the extracellular vesicle surface for clinical molecular biology. J Extracell Vesicles. 2022;11(10):e12260. doi:10.1002/jev2.12260
   PubMed Web of Science ®Google Scholar
• Myers AG, Clark RB. Discovery of macrolide antibiotics effective against multi-drug resistant gram-negative pathogens. Acc Chem Res. 2021;54(7):1635–1645. doi:10.1021/acs.accounts.1c00020
   PubMed Web of Science ®Google Scholar
• Akkus ZB, Nazir I, Jalil A, Tribus M, Bernkop-Schnurch A. Zeta potential changing polyphosphate nanoparticles: a promising approach to overcome the mucus and epithelial barrier. Mol Pharm. 2019;16(6):2817–2825. doi:10.1021/acs.molpharmaceut.9b00355
   PubMedGoogle Scholar
• Lieleg O, Baumgartel RM, Bausch AR. Selective filtering of particles by the extracellular matrix: an electrostatic bandpass. Biophys J. 2009;97(6):1569–1577. doi:10.1016/j.bpj.2009.07.009
   PubMed Web of Science ®Google Scholar
• Agrawal AK, Aqil F, Jeyabalan J, et al. Milk-derived exosomes for oral delivery of paclitaxel. Nanomedicine. 2017;13(5):1627–1636. doi:10.1016/j.nano.2017.03.001
   PubMed Web of Science ®Google Scholar
• Zaid Alkilani A, Musleh B, Hamed R, Swellmeen L, Basheer HA. Preparation and characterization of patch loaded with clarithromycin nanovesicles for transdermal drug delivery. J Funct Biomater. 2023;14(2). doi:10.3390/jfb14020057
   PubMed Web of Science ®Google Scholar
• Kumar PR, Shyale S, Gouda MM, Kumar SS. A sensitive UV spectrophotometric analytical method development, validation and preformulation studies of clarithromycin. Research J Pharm and Tech. 2011;4(2):242–246.
   Google Scholar
• Li Y, Su T, Zhang Y, Huang X, Li J, Li C. Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant Staphylococcus aureus infection. Drug Deliv. 2015;22(5):627–637. doi:10.3109/10717544.2014.880756
   PubMed Web of Science ®Google Scholar
• Wang D, Jiang Q, Dong Z, et al. Nanocarriers transport across the gastrointestinal barriers: the contribution to oral bioavailability via blood circulation and lymphatic pathway. Adv Drug Deliv Rev. 2023;203:115130. doi:10.1016/j.addr.2023.115130
   PubMed Web of Science ®Google Scholar
• Mosallam FM, Bendary MM, Elshimy R, El-Batal AI. Curcumin clarithromycin nano-form a promising agent to fight Helicobacter pylori infections. World J Microbiol Biotechnol. 2023;39(12):324. doi:10.1007/s11274-023-03745-7
   PubMed Web of Science ®Google Scholar
• Nakagawa Y, Itai S, Yoshida T, Nagai T. Physicochemical properties and stability in the acidic solution of a new macrolide antibiotic, clarithromycin, in comparison with erythromycin. Chem Pharm Bull. 1992;40(3):725–728. doi:10.1248/cpb.40.725
   PubMed Web of Science ®Google Scholar
• Pan-In P, Banlunara W, Chaichanawongsaroj N, Wanichwecharungruang S. Ethyl cellulose nanoparticles: clarithomycin encapsulation and eradication of H. pylori. Carbohydr Polym. 2014;109:22–27. doi:10.1016/j.carbpol.2014.03.025
   PubMed Web of Science ®Google Scholar
• Pan-in P, Tachapruetinun A, Chaichanawongsaroj N, Banlunara W, Suksamrarn S, Wanichwecharungruang S. Combating Helicobacter pylori infections with mucoadhesive nanoparticles loaded with Garcinia mangostana extract. Nanomedicine. 2014;9(3):457–468. doi:10.2217/nnm.13.30
   PubMedGoogle Scholar
• Xu C, Soyfoo DM, Wu Y, Xu S. Virulence of Helicobacter pylori outer membrane proteins: an updated review. Eur J Clin Microbiol Infect Dis. 2020;39(10):1821–1830. doi:10.1007/s10096-020-03948-y
   PubMed Web of Science ®Google Scholar
• Pantazopoulou M, Lamprokostopoulou A, Karampela DS, et al. Differential intracellular trafficking of extracellular vesicles in microglia and astrocytes. Cell Mol Life Sci. 2023;80(7):193. doi:10.1007/s00018-023-04841-5
   PubMed Web of Science ®Google Scholar
• Chen C, Cai N, Niu Q, Tian Y, Hu Y, Yan X. Quantitative assessment of lipophilic membrane dye-based labelling of extracellular vesicles by nano-flow cytometry. J Extracell Vesicles. 2023;12(8):e12351. doi:10.1002/jev2.12351
   PubMed Web of Science ®Google Scholar
• Lee SH, Jin KS, Bang OY, et al. Differential migration of mesenchymal stem cells to ischemic regions after middle cerebral artery occlusion in rats. PLoS One. 2015;10(8):e0134920. doi:10.1371/journal.pone.0134920
   PubMed Web of Science ®Google Scholar
• Ichiyama T, Nishikawa M, Yoshitomi T, et al. Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells. Antimicrob Agents Chemother. 2001;45(1):44–47. doi:10.1128/AAC.45.1.44-47.2001
   PubMed Web of Science ®Google Scholar
• Reijnders TDY, Saris A, Schultz MJ, van der Poll T. Immunomodulation by macrolides: therapeutic potential for critical care. Lancet Respir Med. 2020;8(6):619–630. doi:10.1016/S2213-2600(20)30080-1
   PubMed Web of Science ®Google Scholar
• Thaklaewphan P, Ruttanapattanakul J, Monkaew S, et al. Kaempferia parviflora extract inhibits TNF-alpha-induced release of MCP-1 in ovarian cancer cells through the suppression of NF-kappaB signaling. Biomed Pharmacother. 2021;141:111911. doi:10.1016/j.biopha.2021.111911
   PubMed Web of Science ®Google Scholar
• Tsugawa K, Imaizumi T, Watanabe S, Tsuruga K, Yoshida H, Tanaka H. Clarithromycin attenuates the expression of monocyte chemoattractant protein-1 by activating toll-like receptor 4 in human mesangial cells. Clin Exp Nephrol. 2017;21(4):573–578. doi:10.1007/s10157-016-1333-1
   PubMed Web of Science ®Google Scholar
• Tanabe T, Kanoh S, Tsushima K, Yamazaki Y, Kubo K, Rubin BK. Clarithromycin inhibits interleukin-13-induced goblet cell hyperplasia in human airway cells. Am J Respir Cell Mol Biol. 2011;45(5):1075–1083. doi:10.1165/rcmb.2010-0327OC
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Wada H, Rossios C, et al. A novel macrolide solithromycin exerts superior anti-inflammatory effect via NF-kappaB inhibition. J Pharmacol Exp Ther. 2013;345(1):76–84. doi:10.1124/jpet.112.200733
   PubMed Web of Science ®Google Scholar
• Shinkai M, Tamaoki J, Kobayashi H, et al. Clarithromycin delays progression of bronchial epithelial cells from G1 phase to S phase and delays cell growth via extracellular signal-regulated protein kinase suppression. Antimicrob Agents Chemother. 2006;50(5):1738–1744. doi:10.1128/AAC.50.5.1738-1744.2006
   PubMed Web of Science ®Google Scholar
• Shinkai M, Lopez-Boado YS, Rubin BK. Clarithromycin has an immunomodulatory effect on ERK-mediated inflammation induced by Pseudomonas aeruginosa flagellin. J Antimicrob Chemother. 2007;59(6):1096–1101. doi:10.1093/jac/dkm084
   PubMed Web of Science ®Google Scholar
• Wen J, Chen C, Luo M, et al. Notch signaling ligand jagged1 enhances macrophage-mediated response to Helicobacter pylori. Front Microbiol. 2021;12:692832. doi:10.3389/fmicb.2021.692832
   PubMed Web of Science ®Google Scholar
• Zhao C, Lu X, Bu X, Zhang N, Wang W. Involvement of tumor necrosis factor-α in the upregulation of CXCR4 expression in gastric cancer induced by Helicobacter pylori. BMC Cancer. 2010;10(1). doi:10.1186/1471-2407-10-419
   Google Scholar
• Pelisch N, Rosas Almanza J, Stehlik KE, Aperi BV, Kroner A. Use of a self-delivering anti-CCL3 FANA oligonucleotide as an innovative approach to target inflammation after spinal cord injury. eNeuro. 2021;8(2). doi:10.1523/ENEURO.0338-20.2021
   PubMed Web of Science ®Google Scholar
• Karagiannidis I, Salataj E, Said Abu Egal E, Beswick EJ. G-CSF in tumors: aggressiveness, tumor microenvironment and immune cell regulation. Cytokine. 2021;142:155479. doi:10.1016/j.cyto.2021.155479
   PubMed Web of Science ®Google Scholar
• Arnold IC, Zhang X, Urban S, et al. NLRP3 Controls the development of gastrointestinal CD11b(+) dendritic cells in the steady state and during chronic bacterial infection. Cell Rep. 2017;21(13):3860–3872. doi:10.1016/j.celrep.2017.12.015
   PubMed Web of Science ®Google Scholar
• Schneider BG, Piazuelo MB, Sicinschi LA, et al. Virulence of infecting Helicobacter pylori strains and intensity of mononuclear cell infiltration are associated with levels of DNA hypermethylation in gastric mucosae. Epigenetics. 2014;8(11):1153–1161. doi:10.4161/epi.26072
   Web of Science ®Google Scholar
• Cendrowicz E, Sas Z, Bremer E, Rygiel TP. The role of macrophages in cancer development and therapy. Cancer. 2021;13(8). doi:10.3390/cancers13081946
   Google Scholar
• Frauenlob T, Neuper T, Mehinagic M, Dang HH, Boraschi D, Horejs-Hoeck J. Helicobacter pylori infection of primary human monocytes boosts subsequent immune responses to LPS. Front Immunol. 2022;13:847958. doi:10.3389/fimmu.2022.847958
   PubMed Web of Science ®Google Scholar
• Gouzos M, Ramezanpour M, Bassiouni A, Psaltis AJ, Wormald PJ, Vreugde S. Antibiotics affect ROS production and fibroblast migration in an in-vitro model of sinonasal wound healing. Front Cell Infect Microbiol. 2020;10:110. doi:10.3389/fcimb.2020.00110
   PubMed Web of Science ®Google Scholar
• Zimmermann P, Ziesenitz VC, Curtis N, Ritz N. The immunomodulatory effects of macrolides—a systematic review of the underlying mechanisms. Front Immunol. 2018;9. doi:10.3389/fimmu.2018.00302
   PubMed Web of Science ®Google Scholar
• Kaparakis M, Walduck AK, Price JD, et al. Macrophages are mediators of gastritis in acute Helicobacter pylori infection in C57BL/6 mice. Infect Immun. 2008;76(5):2235–2239. doi:10.1128/IAI.01481-07
   PubMed Web of Science ®Google Scholar